Servier
United Arab Emirates
20th June 2025
2506-3412-2
Date posted: Jun 18, 2025
City: Dubai
Country/Region: AE
Type of Contract: Full-time Employment / Unlimited
Job Requisition ID: 9134
Supply Chain & Commercial Excellence Financial Coordinator - Middle East
Servier is a global pharmaceutical group governed by a Foundation. With a strong international presence in 150 countries and total revenue of 5.9 billion euros in 2024, Servier employs 22,000 people worldwide. Servier is an independent group that invests over 20% of its brand-name revenue in Research and Development every year. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. It also integrates the patient's voice at the heart of its activities. A leader in cardiology, the ambition of the Servier Group is to become a renowned and innovative player in oncology. Its growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology, neuroscience, and immuno-inflammatory diseases. To promote access to healthcare for all, the Servier Group also offers a range of quality generic drugs covering most pathologies.
Role: Supply Chain & Commercial Excellence Financial Coordinator – Middle East
Location: Dubai, UAE
Role Purpose:
The SC & CE Financial Coordinator will play a crucial role in managing financial processes and optimizing supply chain operations within the pharmaceutical industry.
Role Responsibilities:
Financial Planning and Analysis
Role Level: | Entry-Level | Work Type: | Contract |
---|---|---|---|
Country: | United Arab Emirates | City: | Dubai |
Company Website: | https://servier.com | Job Function: | Supply Chain & Logistics |
Company Industry/ Sector: |
Pharmaceutical Manufacturing |
Founded to serve health 70 years ago, Servier is a global pharmaceutical group governed by a non-profit Foundation that aspires to make a meaningful social impact for patients and for a sustainable world. The Group’s unique governance model preserves its independence and means it can fully serve its vocation of being committed to therapeutic progress to serve patient needs while adopting a long-term vision. Its employees are fully committed to this shared vocation, which serves as a source of inspiration every day. A world leader in cardiometabolism and venous diseases, Servier has made a major shift into oncology, which represents a new pillar of strategic growth. The Group devotes close to 70% of its R&D budget to this field, with the ambition of becoming a focused and innovative player in the development of treatments targeting rare cancers. Neurology will constitute a future growth driver. Servier is focusing on a limited number of diseases in this area where accurate patient profiling makes it possible to offer a targeted therapeutic response through precision medicine. To promote widespread access to quality care at a lower cost, the Group also offers a range of quality generic drugs covering most pathologies, leveraging well-known brands in France, Eastern Europe and Brazil. In all these areas, the Group takes patient considerations into account at every stage of the medicine life cycle. Headquartered in France, Servier relies on committed teams and strong geographical footprint; its medicines are available in close to 140 countries. In 2023/2024, the Group achieved sales revenue of €5.9 billion and EBITDA of €1.3 billion in 2024 (22.2%). Today, the Group employs over 22,000 people worldwide.--To report a suspected adverse event with a Servier drug, please visit servier.com
Disclaimer: talentmate.com is only a platform to bring jobseekers & employers together. Applicants are advised to research the bonafides of the prospective employer independently. We do NOT endorse any requests for money payments and strictly advice against sharing personal or bank related information. We also recommend you visit Security Advice for more information. If you suspect any fraud or malpractice, email us at abuse@talentmate.com.